Preliminary results of radiation therapy for prostate cancer in human immunodeficiency virus-positive patients (Q45395865)

14 December 2017

title

Preliminary results of radiation therapy for prostate cancer in human immunodeficiency virus-positive patients (English)

1 reference

adaptive radiation therapy

14 December 2017

main subject

0 references

author name string

Tracy Ng

1 reference

14 December 2017

Nicholas F Stein

1 reference

14 December 2017

Jed Kaminetsky

1 reference

14 December 2017

Steven Berman

1 reference

14 December 2017

Hillel Y Marans

1 reference

14 December 2017

Bill McDermott

1 reference

14 December 2017

Anthony M Berson

1 reference

14 December 2017

language of work or name

English

0 references

publication date

14 April 2008

1 reference

14 December 2017

1 reference

14 December 2017

1 reference

14 December 2017

1 reference

14 December 2017

page(s)

1135-8; discussion 1138

1 reference

Prostatic cancer in a patient with asymptomatic HIV infection: are some lives more equal than others?

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Prostate cancer in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Prostate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Increased risk of prostate cancer in HIV infection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Radical prostatectomy in patients infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Should HIV patients be considered a high risk group for the development of prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Disseminated, lethal prostate cancer during human immunodeficiency virus infection presenting with non-specific features. Open questions for urologists, oncologists, and infectious disease specialists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Survival after cancer diagnosis in persons with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.01.022

10.1016/J.UROLOGY.2008.01.022

7 January 2021

Identifiers

DOI

1 reference

14 December 2017

1 reference